Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metalloproteinase-9 Activity in the Plasma of Patients With Non-ST-Elevation Acute Coronary Syndrome††Conflicts of interest: Drs. Egido and Tuñón have participated on advisory boards and have been invited speakers for Pfizer - Gómez-Hernández, Almudena; Sánchez-Galán, Eva; Ortego, Mónica; Martín-Ventura, José Luis; Blanco-Colio, Luis Miguel; Tarín-Vicente, Nieves; Jiménez-Nacher, José Julio; López-Bescos, Lorenzo; Egido, Jesús; Tuñón, José (The American journal of cardiology, 2008)